Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy
Extracellular vesicles (EVs) are cell-derived membrane particles that represent an endogenous mechanism for cell-to-cell communication. Since discovering that EVs have multiple advantages over currently available delivery platforms, such as their ability to overcome natural barriers, intrinsic cell...
Main Authors: | Yifan Ma, Shiyan Dong, Xuefeng Li, Betty Y. S. Kim, Zhaogang Yang, Wen Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.606906/full |
Similar Items
-
Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics
by: Hyosuk Kim, et al.
Published: (2021-12-01) -
Exosome-mimetic nanoplatforms for targeted cancer drug delivery
by: Abi J. Vázquez-Ríos, et al.
Published: (2019-07-01) -
Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source
by: Wanrong Meng, et al.
Published: (2020-01-01) -
Extracellular Vesicles in the Development of Cancer Therapeutics
by: Haoyao Sun, et al.
Published: (2020-08-01) -
Factors Affecting Extracellular Vesicles Based Drug Delivery Systems
by: Isha Gaurav, et al.
Published: (2021-03-01)